It could be argued that JWXYS which exhibits potent antioxidant activity and inhibits free-radical-induced hepatic fibrosis by cytochrome C reduction [12], also contributes to better prognosis for liver cancer patients. Here, CYCS is linked to Hepatic fibrosis.